Cumberland Pharmaceuticals Inc (CPIX) (Q3 2026) Earnings Call Highlights: $100 Million Apotex ...
Cumberland Pharmaceuticals Inc (CPIX) closed a transformational $100 million transaction, ended the quarter with $80.6 million in cash and no debt, and is advancing ifetroban toward an NDA Related Stocks: CPIX ,